Tumor implantation in gastrointestinal wound sites;L'IMPLANTATION TUMORALE DANS LES SITES DE CICATRISATION APRES CHIRURGIE DES CANCERS DIGESTIFS

Journal de Chirurgie

Volumn 133, Issue 4, 1996, Pages 175-182

  Jacquet, P ^a   Elias, D ^b   Sugarbaker, P H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RECURRENCE; DIGESTIVE SYSTEM CANCER; HUMAN; POSTOPERATIVE PERIOD; REVIEW; SURGICAL TECHNIQUE; SURGICAL WOUND;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL ADHESION MOLECULES; CHEMOTHERAPY, ADJUVANT; CICATRIX; DIGESTIVE SYSTEM NEOPLASMS; HUMANS; INJECTIONS, INTRAPERITONEAL; LAPAROSCOPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM SEEDING; RATS; WOUND HEALING;

EID: 0029940442     PISSN: 00217697     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Baker DG, Materson TM, Pace R, Constable WC, Wanebo H. The influence of the surgical wound on local tumor recurrence. Surgery 1989 ; 106 : 525-32.
2. Zirngibl H, Husemann B, Hermanek P. Intraoperative spillage of tumor cells in surgery for rectal cancer. Dis Colon rectum 1990 ; 33 : 610-4.
3. Sugarbaker PH. The natural history of large bowel cancer. Surgical implications. J Exp Clin Cancer Res 1989 ; 8 (Suppl) : 1-12.
4. Guillou PJ. Adjuvant biological response modifiers after major surgery or trauma. Br J Surg 1995 ; 82 : 721-3.
5. Little D, Regan M, Keane RM, Bouchier-Hayes D. Perioperative immune modulation. Surgery 1993 ; 114 : 87-91.
6. Butler TP, Gullino PM. Quantification of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 1975; 35 : 512.
7. Hansen E, Wolff N, Knuechel R, Ruschoff J, Hofstaedter F, Taeger K. Tumor cells in blood shed from the surgical field. Arch Surg 1995 ; 130 : 387-93.
8. Hansen E, Wolff N, Knuechel R, Ruschoff J, Hofstaedter F, Taeger K. Tumor cells in blood shed from the surgical field. Arch Surg 1995 ; 130 : 387-93.
9. Gertsch P, Baer HU, Kraft R, Maddern GJ, Altermatt HJ. Malignant cells are collected on circular staplers. Dis Colon Rectum 1992 ; 35 : 238-41.
10. Leather AJM, Kocjan G, Path MRC, et al. Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer. Dis Colon Rectum 1994 ; 37 : 814-9.
11. Weiss L. Metastasis inefficiency : causes and consequences. Cancer Rev 1986 ; 3 : 1-24.
12. Glaves D, Huben RP, Weiss L. Haematogenous dissemination of cells from human renal adenocarcinomas. Br J Cancer 1988 ; 57 : 32-5.
13. Weiss L, Harlos JP, Elkin G. Measurements of compression of Ehrlich ascites tumor cells and their relevance to hematogenous metastatasis. Biorheol 1991 ; 28 : 185-93.
14. Sugarbaker PH. Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer. World J Surg 1995 ; 19 : 235-40.
15. Nishimura S, Chung YS, Yashiro M et al. Role of adhesion molecule for the interaction between gastric carcinoma cells and the peritoneum in the peritoneal implantation. Proc Am Ass Cancer Res 1995 ; 36 : 402.
16. Moradi MM, Carson LF, Weinberg JB et al. Serum and ascitic fluid levels of Interleukin-1, Interleukin-6, and Tumor Necrosis Factor-Alpha in patients with ovarian epithelial cancer. Cancer 1993 ; 72 : 2433-40.
17. Tsukada K, Katoh H, Suzuki T et al. Correlations of peritoneal fluid Interleukin-6, serum beta-2 microglobulin and urinary beta-2 microglobulin after elective abdominal surgery. APMIS 1993 ; 101 : 409-12.
18. Gotlieb WH, Abrams JS, Watson JM et al. Presence of Interleukin 10 (I1-10) in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine 1992 ; 4 : 385-90.
19. Jacquet P, Sugarbaker PH. Influence of wound healing on gastrointestinal cancer recurrence. Wounds 1995 ; 7 : 40-7.
20. Thomas CG. Tumor cell contamination of the surgical wound : Experimental and clinical observations. Ann Surg 1961 ; 153 : 697-705.
21. Murthy SM, Goldschmidt RA, Rao LN et al. The influence of surgical trauma on experimental metastasis. Cancer 1989 ; 64 : 2035-44.
22. Humphries MJ. Fibronectin and cancer : Rationales for the use of antiadhesives in cancer treatment. Sem Cancer Biol 1993 ; 4 : 293-99.
23. Murthy MS, Scanlon EF, Silverman RH et al. The role of fibronectin in tumor implantation at surgical sites. Clin Exp Metastasis 1993 ; 11 : 159-173.
24. Dvorak HF, Senger DR, Dvorak AM. Fibrin as a component of the tumor trauma : Origins and biological significance. Cancer Metastasis Rev 1983 ; 2 : 41-73.
25. Ruoslathi E, Giancotti FG. Integrins and tumor cell dissemination. Cancer Cells 1989 ; 1 : 119-26.
26. Mauviel A, Uitto J. The extracellular matrix in wound healing : Role of the cytokine network. Wounds 1993 ; 1 : 137-52.
27. Sugarbaker TA, Chang D, Hoslowe P, Sugarbaker PH. Patterns of spread of recurrent intraabdominal sarcoma, in : Sugarbaker PH (Ed.). Peritoneal carcinomatosis : Diagnosis and Treatment. Kluwer Academic Publishers, Boston MA. 1995.
28. Fernandez-Trigo V, Sugarbaker PH. Clinical determinants of treatments failures after cytoreductive surgery and intraperitoneal chemotherapy in patients with pseudomyxoma. Acta Chir Austriaca 1995 ; 27 : 79-83.
29. Jacquet P, Stuart OA, Dalton D, Chang D, Sugarbaker PH. Effect of intraperitoneal chemotherapy and fibrinolytic therapy on tumor implantation in surgical wounds. Submitted for publication.
30. Sugarbaker PH, Cunliffe WJ, Belliveau J et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Sem Oncol 1989 ; 16 (Suppl 6) : 83-97.
31. Gunji Y, Gorelik E. Role of fibrin coagulation in protection of murine tumor cells from destruction by cytotoxix cells. Cancer Res 1988 ; 48 : 5216-21.
32. Dong Z, Radinsky R, Fan D et al. Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells. JNCI 1994 ; 86 : 913-9.
33. Ades EW, Hooper C, Pruckler JM. Cytoreductive therapy of multidrug-resistant hepatocellular carcinoma : Negative regulation of growth using combination differentiation therapy. Pathobiology 1992 ; 60 : 45-8.
34. Turnbull RB, Kyle K, Watson FR et al. Cancer of the colon : The influence of the «no-touch isolation» technic on survival rates. Ann Surg 1967 ; 166 : 420-5.
35. Wiggers T, Jeekel J, Arends JW et al. No-touch isolation technique in colon cancer : A controlled prospective trial. Br J Surg 1988 ; 75 : 409-15.
36. Wexner SD, Cohen SM. Port site metastases after laparoscopic colorectal surgery for cure of malignancy. Br J Surg 1955 ; 82 : 295-98.
37. Cirocco WC, Schwartzman A, Golub RW. Abdominal wall recurrence after laparoscopic colectomy for colon cancer. Surgery 1994 ; 116 : 842-6.
38. Ramos JM, Gupta S, Anthone GJ, Ortega AE, Simons AJ, Beart RW. Laparoscopy and colon cancer. Is the port site at risk ? A preliminary report. Arch Surg 1994 ; 129 : 897-900.
39. Nduka CC, Monson JRT, Menzies-Gow N, Darzi A. Abdominal wall metastases following laparoscopy. Br J Surg 1994 ; 81 : 648-52.
40. Fusco MA, Paluzzi MW. Abdominal wall recurrence after laparoscopic-assisted colectomy for adenocarcinoma of the colon. Report of a case. Dis Colon Rectum 1993 ; 36 : 858-61.
41. Berends FJ, Kazemier G, Bonjer HJ, Lange JF. Subcutaneous metastases after laparoscopic colectomy. Lancet 1994 ; 344 : 58.
42. Jones DB, Guo LW, Reinhard MK et al. The impact of pneumoperitoneum on trocar site implantation of a colon cancer in a hamster model. Dis Colon Rectum 1995 ; 38 : 1182-8.
43. Berman IR. Laparoscopic colectomy for cancer : Some cause for pause. Ann Surg Oncol 1995 ; 2 : 1-2.
44. Levin DR, Moskovitz B. Distilled water versus chemotherapeutic agents for transitional bladder cancer. Eur Urol 1986 ; 12 : 418-21.
45. Southwick HW, Harridge WH, Cole WH. Recurrence at the suture line following resection for carcinoma of the colon. Am J Surg 1962 ; 103 : 86-9.
46. Sweitzer KL, Nathanson SD, Nelson LT, Zachary C. Irrigation does not dislodge or destroy tumor cells adherent to the tumor bed. J Surg Oncol 1993 ; 53 : 184-90.
47. Whalen GF, Ingber DE. Inhibition of tumor cell attachment to extracellular matrix as a method for preventing tumor recurrence in surgical wound. Ann Surg 1989 ; 210 : 758-64.
48. Sugarbaker PH, Zhu BW, Banez Sese G, Shmookler B. Peritoneal carcinomatosis from appendiceal cancer : Results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy. Dis Colon Rectum 1993 ; 36 : 323-9.
49. Sugarbaker PH. Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis. Dis Colon Rectum 1994 ; 37 (Suppl) : 115-22.
50. Markman M. Intraperitoneal therapy in ovarian cancer utilizing agents achieving high local but low systemic exposures. Reg Cancer Treat 1991 ; 3 : 264-8.
51. Dedrick RL, Meyers CE, Bungay PM et al. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 1978 ; 62 ; 1-11.
52. Sugarbaker PH, Gianola FJ, Speyer JC, Wesley R, Barofsky I, Meyers CE. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery 1985 ; 98 : 414-21.
53. Porter JM, McGregor FH, Mullen DC, Silver D. Fibrinolytic activity of mesothelial surfaces. Sug Forum 1969 ; 20 : 80-2.
54. Vipond MN, Whawell SA, Thompson JN, Dudley HAF. Peritoneal fibrinolytic activity and intra-abdominal adhesions. Lancet 1990 ; 335 : 1120-2.
55. Scott-Coombes DM, Whawell SA, Vipond MN, Thompson JN. Human intraperitoneal fibrinolytic response to elective surgery. Br J Surg 1995 ; 82 : 414-7.
56. See WA. Plasminogen activators : Regulators of tumor cell adherence to sites of lower urinary tract surgical trauma. J Urol 1993 ; 150 : 1024-9.
57. Murthy SM, Summaria LJ, Miller RJ, Wyse TB, Goldschmidt RA, Scanlon EF. Inhibition of tumor implantation at sites of trauma by plasminogen activators. Cancer 1991 ; 68 : 1724-30.
58. Zachaski LR, Costantini V, Wojtukiewicz MZ, Memoli CVA, Kudryk BJ. Anticoagulants as cancer therapy. Sem Oncol 1990 ; 17 : 217-27.
59. Humphries MJ, Olden K, Yamada KM. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986 ; 233 : 467-70.
60. Yamamoto K, Murae M. Yasuda M. RGD-containing peptides inhibit experimental peritoneal seeding of human ovarian cancer cells. Acta Obst Gynaec Jpn 1991 ; 12 : 1687-92.
61. Goldstein DS, Lu ML, Hattori RT, Ratliff TL, Loughlin KR, Kavoussi LR. Inhibition of peritoneal tumor-cell implantation : Model for laparoscopic cancer surgery. J Endourol 1993 ; 7 : 237-41.
62. Murthy MS, Weiss BD, Miller RJ, Trueheart R, Scanlon EF. Inhibition of tumor implantation at sites of trauma by Arg-Glu-Asp containing proteins and peptides. Clin Exp Metastasis 1992 ; 10 : 39-47.
63. Hyacinthe LM, Jarret TW, Gordon CS, Vaughan ED, Whalen GF. Inhibition of bladder tumor cell implantation in cauterized urothelium, without inhibition of healing, by a fibronectin-related peptide (GRGDS). Ann Surg Oncol 1995 ; 2 : 450-6.